(Total Views: 696)
Posted On: 12/20/2022 1:06:30 PM
Post# of 155869
"Pourhassan and Kazempour allegedly deceived investors about the timeline and status of CytoDyn’s regulatory submissions..."
There is nothing in this statement that can compromise the results of our clinical trials.
There is nothing in this statement that can compromise the results of our clinical trials.
(6)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
